MOESM1 of Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue

MOESM1 of Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes

Yvonne Ziegler (4247254)
James Moresco (845160)
Patricia Tu (5772065)
John Yates (140156)
Ann Nardulli (5772068)

September 2018

Additional file 1. Table S1. Peptide count, NSAF values, EMPAI values, spectral counts, and % sequen...

MOESM6 of Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

Nina Zila (4927534)
Andrea Bileck (817639)
Besnik Muqaku (817637)
Lukas Janker (4927528)
Ossia Eichhoff (4927531)
Phil Cheng (687262)
Reinhard Dummer (103718)
Mitchell Levesque (4861357)
Christopher Gerner (117547)
Verena Paulitschke (134709)

March 2018

Additional file 6: TableÂ S3. Genes upregulated in melanoma cells by TGFÎ˛ signaling correlating wit...

MOESM1 of Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease

Jonathan Dunne (3454643)
David Lamb (584433)
Brett Delahunt (378516)
Judith Murray (3454634)
Peter Bethwaite (3454628)
Peter Ferguson (3454640)
John Nacey (3454631)
Sven Sondhauss (3454637)
T. Jordan (3454625)

September 2015

Additional file 1: Two-dimensional electrophoresis of proteins extracted from FFPE tissue

MOESM2 of Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue

Florian Unger (2650336)
Nicole Lange (335740)
Jana KrĂźger (3414515)
Carolyn Compton (3414512)
Helen Moore (3414518)
Lokesh Agrawal (3414524)
Hartmut Juhl (506121)
Kerstin David (3414521)

January 2016

Additional file 2: Figure S1. Unaltered expression and/or phosphorylation of the target signaling pr...

MOESM1 of The cancer proteomic landscape and the HUPO Cancer Proteome Project

Connie Jimenez (4798938)
Hui Zhang (7197)
Christopher Kinsinger (4798935)
Edouard Nice (460235)

January 2018

Additional file 1: Table S1. Overview of high-resolution mass spectrometry-based studies of human ca...

MOESM2 of Proteomic profiling identifies markers for inflammation-related tumorâfibroblast interaction

Daniel Drev (4498525)
Andrea Bileck (817639)
Zeynep Erdem (420580)
Thomas Mohr (490787)
Gerald Timelthaler (532192)
Andrea Beer (3328452)
Christopher Gerner (117547)
Brigitte Marian (420584)

October 2017

Additional file 2. Table S1. Proteins identified in colorectal tumors and normal mucosa

Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue

January 2016

abstract: Background Clinical diagnostic research relies upon the collection of tissue samples, and ...

MOESM1 of A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Stefan Enroth (189126)
Malin Berggrund (6035387)
Maria Lycke (6035390)
Martin Lundberg (584387)
Erika Assarsson (58597)
Matts Olovsson (3225774)
Karin StĂĽlberg (6035393)
Karin Sundfeldt (754806)
Ulf Gyllensten (13773)

December 2018

Additional file 1: TableÂ 1. P-values of individual proteins in the discovery step

MOESM3 of An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Qing Li (84975)
Punit Shah (1326501)
Yuan Tian (225002)
Yingwei Hu (1837675)
Richard Roden (3191487)
Hui Zhang (7197)
Daniel Chan (3873598)

May 2017

Additional file 3: Table S3. Proteomic analysis from additional 2 benign and 2 HGSC tissues in iTRAQ...

Identification of the Ischemic Pathway Level Changes by Integrating Temporal Phosphoproteome in Ovarian Cancer

Budak, Gungor
Fraenkel, Ernest
Tunçbağ, Nurcan

September 2017

The temporal proteome studies aim to evaluate changes in the proteome and phosphoproteome when there...

Table_1_Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer.docx

Maosen Huang (13826986)
Yancen Wu (16493628)
Linyao Cheng (13826989)
Lihua Fu (4372219)
Haochao Yan (16493631)
Haiming Ru (9959971)
Xianwei Mo (612819)
Linhai Yan (13826995)
Zijie Su (12403831)

July 2023

BackgroundGlucose metabolic reprogramming (GMR) is a cardinal feature of carcinogenesis and metastas...

Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels

Mertins, P.
Yang, F.
Liu, T.
Mani, D.R.
Petyuk, V.A.
Gillette, M.A.
Clauser, K.R.
Qiao, J.W.
Gritsenko, M.A.
Moore, R.J.
Levine, D.A.
Townsend, R.
Erdmann-Gilmore, P.
Snider, J.E.
Davies, S.R.
Ruggles, K.V.
Fenyo, D.
Kitchens, R.T.
Li, S.
Olvera, N.
Dao, F.
Rodriguez, H.
Chan, D.W.
Liebler, D.
White, F.
Rodland, K.D.
Mills, G.B.
Smith, R.D.
Paulovich, A.G.
Ellis, M.
Carr, S.A.

July 2014

Protein abundance and phosphorylation convey important information about pathway activity and molecu...

MOESM1 of Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study

Agata Abramowicz (3512672)
Anna Wojakowska (792919)
Agnieszka Gdowicz-Klosok (3512666)
Joanna Polanska (398872)
Pawel Rodziewicz (2434057)
Pawel Polanowski (3512675)
Agnieszka Namysl-Kaletka (3512669)
Monika Pietrowska (777995)
Jerzy Wydmanski (3512678)
Piotr Widlak (777996)

September 2015

Additional file 1. Detailed description of differentiating components of serum proteome

Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global

October 2016

Protein abundance and phosphorylation convey impor-tant information about pathway activity and molec...

MOESM2 of Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

Nina Zila (4927534)
Andrea Bileck (817639)
Besnik Muqaku (817637)
Lukas Janker (4927528)
Ossia Eichhoff (4927531)
Phil Cheng (687262)
Reinhard Dummer (103718)
Mitchell Levesque (4861357)
Christopher Gerner (117547)
Verena Paulitschke (134709)

March 2018

Additional file 2: TableÂ S1. Clinical table with age, gender, treatment, response distribution, PFS...

MOESM1 of Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes

Yvonne Ziegler (4247254)
James Moresco (845160)
Patricia Tu (5772065)
John Yates (140156)
Ann Nardulli (5772068)

September 2018

Additional file 1. Table S1. Peptide count, NSAF values, EMPAI values, spectral counts, and % sequen...

MOESM6 of Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

Nina Zila (4927534)
Andrea Bileck (817639)
Besnik Muqaku (817637)
Lukas Janker (4927528)
Ossia Eichhoff (4927531)
Phil Cheng (687262)
Reinhard Dummer (103718)
Mitchell Levesque (4861357)
Christopher Gerner (117547)
Verena Paulitschke (134709)

March 2018

Additional file 6: TableÂ S3. Genes upregulated in melanoma cells by TGFÎ˛ signaling correlating wit...

MOESM1 of Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease

Jonathan Dunne (3454643)
David Lamb (584433)
Brett Delahunt (378516)
Judith Murray (3454634)
Peter Bethwaite (3454628)
Peter Ferguson (3454640)
John Nacey (3454631)
Sven Sondhauss (3454637)
T. Jordan (3454625)

September 2015

Additional file 1: Two-dimensional electrophoresis of proteins extracted from FFPE tissue

MOESM2 of Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue

Florian Unger (2650336)
Nicole Lange (335740)
Jana KrĂźger (3414515)
Carolyn Compton (3414512)
Helen Moore (3414518)
Lokesh Agrawal (3414524)
Hartmut Juhl (506121)
Kerstin David (3414521)

January 2016

Additional file 2: Figure S1. Unaltered expression and/or phosphorylation of the target signaling pr...

MOESM1 of The cancer proteomic landscape and the HUPO Cancer Proteome Project

Connie Jimenez (4798938)
Hui Zhang (7197)
Christopher Kinsinger (4798935)
Edouard Nice (460235)

January 2018

Additional file 1: Table S1. Overview of high-resolution mass spectrometry-based studies of human ca...

MOESM2 of Proteomic profiling identifies markers for inflammation-related tumorâfibroblast interaction

Daniel Drev (4498525)
Andrea Bileck (817639)
Zeynep Erdem (420580)
Thomas Mohr (490787)
Gerald Timelthaler (532192)
Andrea Beer (3328452)
Christopher Gerner (117547)
Brigitte Marian (420584)

October 2017

Additional file 2. Table S1. Proteins identified in colorectal tumors and normal mucosa

Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue

January 2016

abstract: Background Clinical diagnostic research relies upon the collection of tissue samples, and ...

MOESM1 of A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer

Stefan Enroth (189126)
Malin Berggrund (6035387)
Maria Lycke (6035390)
Martin Lundberg (584387)
Erika Assarsson (58597)
Matts Olovsson (3225774)
Karin StĂĽlberg (6035393)
Karin Sundfeldt (754806)
Ulf Gyllensten (13773)

December 2018

Additional file 1: TableÂ 1. P-values of individual proteins in the discovery step

MOESM3 of An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

Qing Li (84975)
Punit Shah (1326501)
Yuan Tian (225002)
Yingwei Hu (1837675)
Richard Roden (3191487)
Hui Zhang (7197)
Daniel Chan (3873598)

May 2017

Additional file 3: Table S3. Proteomic analysis from additional 2 benign and 2 HGSC tissues in iTRAQ...

Identification of the Ischemic Pathway Level Changes by Integrating Temporal Phosphoproteome in Ovarian Cancer

Budak, Gungor
Fraenkel, Ernest
Tunçbağ, Nurcan

September 2017

The temporal proteome studies aim to evaluate changes in the proteome and phosphoproteome when there...

Table_1_Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer.docx

Maosen Huang (13826986)
Yancen Wu (16493628)
Linyao Cheng (13826989)
Lihua Fu (4372219)
Haochao Yan (16493631)
Haiming Ru (9959971)
Xianwei Mo (612819)
Linhai Yan (13826995)
Zijie Su (12403831)

July 2023

BackgroundGlucose metabolic reprogramming (GMR) is a cardinal feature of carcinogenesis and metastas...

Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels

Mertins, P.
Yang, F.
Liu, T.
Mani, D.R.
Petyuk, V.A.
Gillette, M.A.
Clauser, K.R.
Qiao, J.W.
Gritsenko, M.A.
Moore, R.J.
Levine, D.A.
Townsend, R.
Erdmann-Gilmore, P.
Snider, J.E.
Davies, S.R.
Ruggles, K.V.
Fenyo, D.
Kitchens, R.T.
Li, S.
Olvera, N.
Dao, F.
Rodriguez, H.
Chan, D.W.
Liebler, D.
White, F.
Rodland, K.D.
Mills, G.B.
Smith, R.D.
Paulovich, A.G.
Ellis, M.
Carr, S.A.

July 2014

Protein abundance and phosphorylation convey important information about pathway activity and molecu...

MOESM1 of Identification of serum proteome signatures of locally advanced and metastatic gastric cancer: a pilot study

Agata Abramowicz (3512672)
Anna Wojakowska (792919)
Agnieszka Gdowicz-Klosok (3512666)
Joanna Polanska (398872)
Pawel Rodziewicz (2434057)
Pawel Polanowski (3512675)
Agnieszka Namysl-Kaletka (3512669)
Monika Pietrowska (777995)
Jerzy Wydmanski (3512678)
Piotr Widlak (777996)

September 2015

Additional file 1. Detailed description of differentiating components of serum proteome

Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global

October 2016

Protein abundance and phosphorylation convey impor-tant information about pathway activity and molec...

MOESM2 of Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

Nina Zila (4927534)
Andrea Bileck (817639)
Besnik Muqaku (817637)
Lukas Janker (4927528)
Ossia Eichhoff (4927531)
Phil Cheng (687262)
Reinhard Dummer (103718)
Mitchell Levesque (4861357)
Christopher Gerner (117547)
Verena Paulitschke (134709)

March 2018

Additional file 2: TableÂ S1. Clinical table with age, gender, treatment, response distribution, PFS...

MOESM1 of Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes

Yvonne Ziegler (4247254)
James Moresco (845160)
Patricia Tu (5772065)
John Yates (140156)
Ann Nardulli (5772068)

September 2018

Additional file 1. Table S1. Peptide count, NSAF values, EMPAI values, spectral counts, and % sequen...

MOESM6 of Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastases

Nina Zila (4927534)
Andrea Bileck (817639)
Besnik Muqaku (817637)
Lukas Janker (4927528)
Ossia Eichhoff (4927531)
Phil Cheng (687262)
Reinhard Dummer (103718)
Mitchell Levesque (4861357)
Christopher Gerner (117547)
Verena Paulitschke (134709)

March 2018

Additional file 6: TableÂ S3. Genes upregulated in melanoma cells by TGFÎ˛ signaling correlating wit...

MOESM1 of Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease

Jonathan Dunne (3454643)
David Lamb (584433)
Brett Delahunt (378516)
Judith Murray (3454634)
Peter Bethwaite (3454628)
Peter Ferguson (3454640)
John Nacey (3454631)
Sven Sondhauss (3454637)
T. Jordan (3454625)

September 2015

Additional file 1: Two-dimensional electrophoresis of proteins extracted from FFPE tissue

MOESM1 of Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue

Abstract

Extracted data

MOESM1 of Nanoproteomic analysis of ischemia-dependent changes in signaling protein phosphorylation in colorectal normal and cancer tissue

Abstract

Extracted data

Related items

Related items